The new funds will allow the company to test its multi-node PI3K treatment approach in a new endometrial cancer trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback